Palomino Laboratories Inc.
PALX· OTC
PALXPalomino Laboratories Inc.
Filed May 15, 2025 · 10-Q · 45 days after period end · 0001213900-25-044348
| Metric | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Net Income | -$985.17K | -$247.00 | -$4.25K |
| EPS Diluted | -$0.44 | -$0.01 | -$0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palomino Laboratories Inc. · CIK 1938569 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end
